Ikaria Inc.

Ikaria is developing technology that triggers a natural hibernation-like mechanism that drastically lowers cells' metabolism and thus their need for oxygen. The company believes that inducing hibernation could buy time for blood-deprived tissues and minimize damage in cardiac surgery, strokes, heart attacks, and organ transplants.